We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SEQUENT.NSE

Price
137.18
Stock movement up
+5.09 (3.85%)
Company name
Sequent Scientific Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
34.21B
Ent value
41.73B
Price/Sales
2.36
Price/Book
4.61
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
207.60
Forward P/E
-
PEG
-
EPS growth
-
1 year return
9.70%
3 year return
-0.02%
5 year return
17.99%
10 year return
-
Last updated: 2025-04-15

DIVIDENDS

SEQUENT.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E207.60
Price to OCF110.66
Price to FCF110.66
Price to EBITDA149.42
EV to EBITDA182.28

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales2.36
Price to Book4.61
EV to Sales2.88

FINANCIALS

Per share

Per share data
Current share count249.35M
EPS (TTM)0.63
FCF per share (TTM)1.18

Income statement

Income statement data
Revenue (TTM)14.49B
Gross profit (TTM)4.34B
Operating income (TTM)1.59B
Net income (TTM)164.77M
EPS (TTM)0.63
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)29.97%
Operating margin (TTM)10.94%
Profit margin (TTM)1.14%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash680.50M
Net receivables0.00
Total current assets8.29B
Goodwill2.45B
Intangible assets578.50M
Property, plant and equipment0.00
Total assets15.62B
Accounts payable2.50B
Short/Current long term debt4.89B
Total current liabilities4.89B
Total liabilities8.20B
Shareholder's equity7.42B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)309.10M
Capital expenditures (TTM)0.00
Free cash flow (TTM)309.10M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity2.22%
Return on Assets1.05%
Return on Invested Capital1.77%
Cash Return on Invested Capital3.33%

STOCK INFORMATION

Stock chart

Stock price data
Open137.00
Daily high139.98
Daily low134.31
Daily Volume536K
All-time high323.60
1y analyst estimate133.50
Beta0.82
EPS (TTM)0.63
Dividend per share-
Ex-div date8 Sep 2021
Next earnings date13 May 2025

Downside potential

Downside potential data
SEQUENT.NSES&P500
Current price drop from All-time high-57.61%-12.89%
Highest price drop-80.76%-56.47%
Date of highest drop28 Feb 20239 Mar 2009
Avg drop from high-47.50%-11.07%
Avg time to new high98 days12 days
Max time to new high1190 days1805 days
COMPANY DETAILS
SEQUENT.NSE (Sequent Scientific Limited) company logo
Marketcap
34.21B
Marketcap category
Large-cap
Description
Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
Employees
1195
Website
https://www.sequent.in
Investor relations
-
SEC filings
SEQUENT.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved